Risk stratification for sudden cardiac death: is there a clinical role for T wave alternans?
Michael J Cutler1, David S Rosenbaum
1Heart and Vascular Research Center, Case Western Reserve University, Cleveland, Ohio 44109-1998, USA.
Insights
Sudden cardiac death (SCD) is increasing. Microvolt T-wave alternans (TWA) may improve risk stratification for implantable cardioverter-defibrillator (ICD) therapy beyond left ventricular ejection fraction (LVEF).
Area of Science:
- Cardiology
- Electrophysiology
- Biomedical Engineering
Background:
- Sudden cardiac death (SCD) represents a growing proportion of cardiovascular mortality.
- Current risk stratification for prophylactic implantable cardioverter-defibrillators (ICDs) primarily relies on left ventricular ejection fraction (LVEF), which has limitations.
- Identifying patients who will benefit from ICD implantation is crucial for reducing SCD.
Purpose of the Study:
- To review the clinical utility of microvolt T-wave alternans (TWA) in risk stratification for SCD.
- To explore TWA as a potential marker for arrhythmic risk beyond LVEF.
- To discuss the role of TWA in guiding prophylactic ICD implantation decisions.
Main Methods:
- Literature review of studies investigating TWA and SCD risk.
- Analysis of TWA's association with electrophysiological substrates and arrhythmogenesis.
- Evaluation of TWA's noninvasive assessment of arrhythmic risk.
Main Results:
- T-wave alternans (TWA) at the microvolt level is emerging as a significant predictor of arrhythmic events.
- TWA provides insights into the underlying electrophysiological substrate linked to arrhythmia mechanisms.
- Evidence suggests TWA can enhance risk stratification for sudden cardiac death.
Conclusions:
- Microvolt T-wave alternans (TWA) shows promise as a valuable tool for SCD risk stratification.
- TWA may offer complementary information to LVEF in identifying patients for ICD therapy.
- Further clinical integration of TWA could optimize prophylactic ICD implantation strategies.
Abstract:
The proportion of cardiovascular deaths attributable to sudden cardiac death (SCD) is on the rise. Herein lies the rationale for developing risk stratification strategies to predict who will benefit from prophylactic implantable cardioverter-defibrillator (ICD) implantation. Current guidelines recommend prophylactic ICD therapy in patients with reduced left ventricular ejection fraction (LVEF). However, there are clear limitations in using LVEF alone to decide who should receive an ICD. There is mounting evidence that microvolt-level T-wave alternans (TWA) is an important marker of arrhythmic risk. TWA is appealing because it noninvasively probes the underlying electrophysiological substrate and has been linked to cellular mechanisms for arrhythmias. This review considers the clinical role of TWA for risk stratification of SCD.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Dysrhythmias II: Classification of Tachyarrhythmias
Acute Coronary Syndrome I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
